BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 1497017)

  • 1. New therapeutic agents in the treatment of inflammatory bowel disease.
    Geier DL; Miner PB
    Am J Med; 1992 Aug; 93(2):199-208. PubMed ID: 1497017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing therapy for inflammatory bowel disease.
    Robinson M
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Ann Intern Med; 1990 Jan; 112(1):50-60. PubMed ID: 2152845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current medical therapy for inflammatory bowel disease.
    Bonner GF
    South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic therapy for inflammatory bowel disease.
    Hirschfeld S; Clearfield HR
    Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of inflammatory bowel disease: summary of the proceedings of the Subcommittee on Immunosuppressive Use in IBD.
    Markowitz J; Daum F; Cohen SA; Glassman M; Holmes RD; Piccoli D; Rossi TM; Treem WR; Ulshen MH; Winter HS
    J Pediatr Gastroenterol Nutr; 1991 May; 12(4):411-23. PubMed ID: 1678006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer pharmacologic agents for the therapy of inflammatory bowel disease.
    Ruderman WB
    Med Clin North Am; 1990 Jan; 74(1):133-53. PubMed ID: 2404172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing conventional therapy for inflammatory bowel disease.
    Schwartz M; Cohen R
    Curr Gastroenterol Rep; 2008 Dec; 10(6):585-90. PubMed ID: 19006615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional drug therapy in inflammatory bowel disease.
    Griffin MG; Miner PB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):509-21. PubMed ID: 8809233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease.
    Van Rosendaal GM
    CMAJ; 1989 Jul; 141(2):113-23; discussion 123-4. PubMed ID: 2568163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer treatments for inflammatory bowel disease.
    Stotland BR; Lichtenstein GR
    Prim Care; 1996 Sep; 23(3):577-608. PubMed ID: 8888346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W; Wolf LM; Grotz W; Grieshaber M
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory bowel diseases: conservative therapy].
    Bansky G
    Ther Umsch; 1991 Jul; 48(7):464-70. PubMed ID: 1926006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative tolerability of treatments for inflammatory bowel disease.
    Stein RB; Hanauer SB
    Drug Saf; 2000 Nov; 23(5):429-48. PubMed ID: 11085348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease.
    Brzezinski A; Rankin GB; Seidner DL; Lashner BA
    Cleve Clin J Med; 1995; 62(5):317-23. PubMed ID: 7586488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR
    CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.